Evidence map›Paper›PMID 24578379›Full record

SynthesisArteriosclerosis, thrombosis, and vascular biology2014

Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.

Jie Huang, Jennifer E Huffman, Munekazu Yamakuchi, Munekazu Yamkauchi, Stella Trompet, Folkert W Asselbergs, Maria Sabater-Lleal, David-Alexandre Trégouët, Wei-Min Chen, Nicholas L Smith and 86 more

Erratum issuedOpen access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Arteriosclerosis, thrombosis, and vascular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

96 authors at 20 institutions in 10 countries.

Jie HuangFrom National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (J.H., A.D.J., C.J.O.); Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (J.H., A.D.J., C.J.O.); MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, Scotland, United Kingdom (J.E.H., V.V., A.F.W., C.H.); The Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY (M.Y., C.J.L.); Departments of Cardiology (S.T., J.W.J.), Gerontology and Geriatrics (S.T., A.J.M.d.C., R.G.J.W.), and Molecular Epidemiology (P.E.S.), Leiden University Medical Center, the Netherlands; Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands (F.W.A.); Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, the Netherlands (F.W.A.); Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom (F.W.A.); Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit, Department of Medicine (M.S.-L., L.F., P.E., A.H.), Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden; INSERM UMRS 937, Pierre et Marie Curie University, Paris, France (D.-A.T., V.T., T.O.M., F.C.); ICAN Institute for Cardiometabolism and Nutrion, Paris, France (D.-A.T., V.T., F.C.); Departments of Public Health Sciences (W.M.C., B.B.W., F.C.) and Biochemistry and Molecular Genetics (M.M.S.), Center for Public Health Genomics, University of Virginia, Charlottesville, VA; Departments of Epidemiology (N.L.S., B.M.P., B.M.), Medicine (B.M.P., J.C.B.), and Health Services (B.M.P.), University of Washington, Seattle, WA; Group Health Research Institute, Group Health Cooperative, Seattle, WA (N.L.S., B.M.P.); Seattle Epidemiologic Research and Information Center, VA Office of Research and
Jennifer E Huffman
Munekazu Yamakuchi
Munekazu Yamkauchi
Stella Trompet
Folkert W Asselbergs
Maria Sabater-Lleal
David-Alexandre Trégouët
Wei-Min Chen
Nicholas L Smith
Marcus E Kleber
So-Youn Shin
Diane M Becker
Weihong Tang
Abbas Dehghan
Andrew D Johnson
Vinh Truong
Lasse Folkersen
Qiong Yang
Tiphaine Oudot-Mellkah
Brendan M Buckley
Jason H Moore
Frances M K Williams
Harry Campbell
Günther Silbernagel
Veronique Vitart
Igor Rudan
Geoffrey H Tofler
Gerjan J Navis
Anita Destefano
Alan F Wright
Ming-Huei Chen
Anton J M de Craen
Bradford B Worrall
Alicja R Rudnicka
Ann Rumley
Ebony B Bookman
Bruce M Psaty
Fang Chen
Keith L Keene
Oscar H Franco
Bernhard O Böhm
Andre G Uitterlinden
Angela M Carter
J Wouter Jukema
Naveed Sattar
Joshua C Bis
Mohammad A Ikram
Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) Consortium Neurology Working Group
Michèle M Sale
Barbara McKnight
Myriam Fornage
Ian Ford
Kent Taylor
P Eline Slagboom
Wendy L McArdle
Fang-Chi Hsu
Anders Franco-Cereceda
Alison H Goodall
Lisa R Yanek
Karen L Furie
Mary Cushman
Albert Hofman
Jacqueline C M Witteman
Aaron R Folsom
Saonli Basu
Nena Matijevic
Wiek H van Gilst
James F Wilson
Rudi G J Westendorp
Sekar Kathiresan
Muredach P Reilly
CARDIoGRAM Consortium
Russell P Tracy
Ozren Polasek
Bernhard R Winkelmann
Peter J Grant
Hans L Hillege
Francois Cambien
David J Stott
Gordon D Lowe
Timothy D Spector
James B Meigs
Winfried Marz
Per Eriksson
Lewis C Becker
Pierre-Emmanuel Morange
Nicole Soranzo
Scott M Williams
Caroline Hayward
Pim van der Harst
Anders Hamsten
Charles J Lowenstein
David P Strachan
Christopher J O'Donnell
CHARGE Consortium Hemostatic Factor Working Group
National Heart Lung and Blood Institute · USErasmus University Rotterdam · NLKarolinska Institutet · SELeiden University · NLUniversity of Virginia · USBoston University · USInserm · FRNational Institutes of Health · USSeattle University · USUniversity of Edinburgh · GBUniversity of Minnesota System · USJohns Hopkins University · USKing's College London · GBThe University of Texas Health Science Center at Houston · USUniversity of Bristol · GBUniversity of Glasgow · GBUniversity of Groningen · NLBroad Institute · USBrown University · USCedars-Sinai Medical Center · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Stat3 in Post-Ischemic Myocardial InflammationP01HL065608 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BECKER, LEWIS C · 2000 to 2011
$22.0M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2003 to 2011
$21.9M
Vitamin Intervention for Stroke Prevention (VISP)R01NS034447 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI TOOLE, JAMES F · 1996 to 2006
$18.0M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
Chief Scientist Office CZB/4/710Intramural NIH HHS Z99 HL999999Intramural NIH HHS ZIA HL006002Medical Research Council G0000934Medical Research Council MC_PC_U127561128NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NCATS NIH HHS UL1 TR001079NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR00052NCRR NIH HHS P20 RR018787NCRR NIH HHS RR018787NCRR NIH HHS UL1 RR033176NCRR NIH HHS UL1RR033176NHGRI NIH HHS U01 HG005157NHGRI NIH HHS U01 HG005160NHLBI NIH HHS 1U01 HL072518NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS HL080295NHLBI NIH HHS HL087652NHLBI NIH HHS HL105756NHLBI NIH HHS HL65234NHLBI NIH HHS HL67466NHLBI NIH HHS N01 HC015103NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC075150NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085086NHLBI NIH HHS P01 HL056091NHLBI NIH HHS P01 HL065608NHLBI NIH HHS P01 HL56091NHLBI NIH HHS P01 HL65608NHLBI NIH HHS R01 HL059684NHLBI NIH HHS R01 HL065234NHLBI NIH HHS R01 HL067466NHLBI NIH HHS R01 HL074061NHLBI NIH HHS R01 HL078635NHLBI NIH HHS R01 HL080295NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL093029NHLBI NIH HHS R01-HL093029NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01 HL78635NHLBI NIH HHS U01 HL072518NHLBI NIH HHS U01 HL080295NHLBI NIH HHS U01 HL096917NIA NIH HHS AG-023629NIA NIH HHS AG023629NIA NIH HHS AG-027058NIA NIH HHS AG033193NIA NIH HHS AG08122NIA NIH HHS AG-20098NIA NIH HHS P30 AG010129NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG015928NIA NIH HHS R01 AG020098NIA NIH HHS R01 AG023629NIA NIH HHS R01 AG027058NIA NIH HHS R01 AG033193NIA NIH HHS R56 AG020098NIA NIH HHS R56 AG023629NIDDK NIH HHS DK063491NIDDK NIH HHS K24 DK080140NIDDK NIH HHS P30 DK063491NIDDK NIH HHS U01 DK062418NINDS NIH HHS NS17950NINDS NIH HHS R01 NS017950NINDS NIH HHS R01 NS034447NINDS NIH HHS R01 NS34447NLM NIH HHS LM010098NLM NIH HHS R01 LM010098Wellcome Trust
6 · The paper itself

Abstract

objectiveTissue plasminogen activator (tPA), a serine protease, catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis. In some populations, elevated plasma levels of tPA have been associated with myocardial infarction and other cardiovascular diseases. We conducted a meta-analysis of genome-wide association studies to identify novel correlates of circulating levels of tPA. APPROACH AND

resultsFourteen cohort studies with tPA measures (N=26 929) contributed to the meta-analysis. Three loci were significantly associated with circulating tPA levels (P<5.0×10(-8)). The first locus is on 6q24.3, with the lead single nucleotide polymorphism (SNP; rs9399599; P=2.9×10(-14)) within STXBP5. The second locus is on 8p11.21. The lead SNP (rs3136739; P=1.3×10(-9)) is intronic to POLB and <200 kb away from the tPA encoding the gene PLAT. We identified a nonsynonymous SNP (rs2020921) in modest linkage disequilibrium with rs3136739 (r(2)=0.50) within exon 5 of PLAT (P=2.0×10(-8)). The third locus is on 12q24.33, with the lead SNP (rs7301826; P=1.0×10(-9)) within intron 7 of STX2. We further found evidence for the association of lead SNPs in STXBP5 and STX2 with expression levels of the respective transcripts. In in vitro cell studies, silencing STXBP5 decreased the release of tPA from vascular endothelial cells, whereas silencing STX2 increased the tPA release. Through an in silico lookup, we found no associations of the 3 lead SNPs with coronary artery disease or stroke.

conclusionsWe identified 3 loci associated with circulating tPA levels, the PLAT region, STXBP5, and STX2. Our functional studies implicate a novel role for STXBP5 and STX2 in regulating tPA release.

Indexed as

AgedCells, CulturedCoronary Artery DiseaseEndothelial CellsEuropeFemaleGene Expression RegulationGene SilencingGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMiddle AgedNerve Tissue ProteinsPhenotypeNerve Tissue ProteinsPLAT protein, humanR-SNARE ProteinsSTX2 protein, humanSTXBP5 protein, humanSyntaxin 1Tissue Plasminogen Activatorfibrinolysisgenome-wide association studyhemostasismeta-analysistissue plasminogen activator

Identifiers

PMID24578379
PMCPMC4009733
OpenAlexW2042131951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.